BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

WRN inhibition for four cancer types with microsatellite instability

Sandi Wong
April 16, 2019 7:57 PM UTC

INDICATION: Colorectal cancer; endometrial cancer; gastric cancer; ovarian cancer...

BCIQ Company Profiles

Boehringer Ingelheim GmbH

Broad Institute of Mit and Harvard

Dana-Farber Cancer Institute

Wellcome Sanger Institute

BCIQ Target Profiles

Werner syndrome RecQ like helicase (WRN)

BCIQ Company Profiles

Boehringer Ingelheim GmbH

Broad Institute of Mit and Harvard

Dana-Farber Cancer Institute

Wellcome Sanger Institute

BCIQ Target Profiles

Werner syndrome RecQ like helicase (WRN)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2025 BioCentury Inc. All Rights Reserved.
Copyright © 2025 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS